46
Participants
Start Date
May 24, 2018
Primary Completion Date
January 20, 2023
Study Completion Date
April 30, 2024
Entinostat
Entinostat should be taken 1-2 hours prior to the HD IL-2 infusion. Dose reductions for entinostat should be followed. Entinostat will continue after high dose IL-2 every 2 weeks
Interleukin-2
In the event of clinical benefit after a course of HD IL-2 (stable disease or tumor shrinkage) patients will receive a second treatment course of HD IL-2 therapy. Patients with evidence of tumor shrinkage after the 2nd HD IL-2 treatment course may receive a 3rd treatment course of HD IL-2.
Indiana Univeristy Melvin and Bren Simon Cancer Center, Indianapolis
Rush University Medical Center, Chicago
Nebraska Methodist Hospital, Omaha
Hematology Oncology Clinic, LLC, Baton Rouge
Univeristy of Southern California, Los Angeles
Collaborators (1)
Indiana University Melvin and Bren Simon Cancer Center
OTHER
Syndax Pharmaceuticals
INDUSTRY
Clinigen, Inc.
INDUSTRY
Roberto Pili
OTHER